The videogame retailer’s shares jumped following the latest cryptic post from influential trader Keith Gill, aka “Roaring ...
Dan Ives, Wedbush global head of technology research, joins 'Closing Bell: Overtime' to discuss Salesforce after the ...
What makes that call particularly surprising is that most pundits are still skeptical about Palantir. Among the 20 analysts ...
While retail investors might base their trades on memes posted by Roaring Kitty, a leading Wall Street analyst is warning ...
We recently compiled a list of the 12 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...
Musk reacted on his X social media platform to the ruling on Monday by Court of Chancery Judge Kathleen McCormick.
DR Horton Inc (DHI) stock saw a decline, ending the day at $158.51 which represents a decrease of $-1.17 or -0.73% from the prior close of $159.68. The stock opened at $161.94 and touched a low of ...
Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on Salesforce (CRM – Research Report), with a price target of ...
Wedbush analyst Daniel Ives says that in “another Twilight Zone” legal move from Chancellor McCormick of the Delaware Court of Chancery yet again blocked Elon Musk’s $56B pay package that ...
Wedbush Securities Managing Director of Equity Research David Chiaverini joined Market Domination to provide insights into the fintech landscape. Chiaverini observed that buy now, pay later (BNPL ...
Tesla (TSLA, $845.00) stock has the potential to reach $950 per share, says Wedbush analyst Daniel Ives. But he still doesn’t think you should buy it. The 11 Best Growth Stocks to Buy for 2021 ...